Abstract:Calcium channel blockers (CCBs) overdose can be life-threatening when manifest as catastrophic shock and non-cardiogenic pulmonary edema. We describe a case of massive overdose of multiple medications, including sustained-release verapamil, which was resistant to conventional support. Initial treatment for CCB overdose is primarily supportive, and includes fluid resuscitation. The mechanism of non-cardiogenic pulmonary edema is not well known, and reported cases have been successfully treated with mechanical v… Show more
“…[11] CCBs directly antagonise the voltagegated L-type calcium channels, which are found in peripheral vascular smooth muscle, cardiomyocytes and the pacemaker cells that form the cardiac conducting system. [11,13,14] Outside the cardiovascular system, voltage-gated L-type calcium channels are found in the beta cells of the pancreas, central nervous system and skeletal muscle. [11,13,14] Non-dihydropyridine CCBs are used primarily to treat angina or cardiac arrhythmias.…”
Section: Pharmacologymentioning
confidence: 99%
“…[11,13,14] Outside the cardiovascular system, voltage-gated L-type calcium channels are found in the beta cells of the pancreas, central nervous system and skeletal muscle. [11,13,14] Non-dihydropyridine CCBs are used primarily to treat angina or cardiac arrhythmias. [11,13] They are lipophilic and have a higher affinity for cardiomyocytes than the dihydropyridine agents, where they reduce the influx of calcium during phase two of the action potential.…”
Calcium channel blockers (CCBs) are commonly used in South Africa (SA) in the management of hypertension and other cardiovascular disease. Their ubiquitous availability makes them a common agent in drug overdose (OD), whether through accidental ingestion or deliberate self-harm. It is essential that medical practitioners know how to recognise and manage CCB OD, as severe CCB OD is often fatal. As there is a lack of local literature in SA, we highlight the general principles of management of CCB OD, as well as complications and problems that may be encountered during treatment. This narrative review is based on existing clinical guidelines, retrospective studies and systematic reviews on the emergency management of CCB OD. High-dose insulin euglycaemic therapy has become the mainstay of treatment in severe CCB OD. The rationale, the recommended protocol for its use and its adverse effects are described.S Afr Med J 2019;109(9):635-638. https://doi.
“…[11] CCBs directly antagonise the voltagegated L-type calcium channels, which are found in peripheral vascular smooth muscle, cardiomyocytes and the pacemaker cells that form the cardiac conducting system. [11,13,14] Outside the cardiovascular system, voltage-gated L-type calcium channels are found in the beta cells of the pancreas, central nervous system and skeletal muscle. [11,13,14] Non-dihydropyridine CCBs are used primarily to treat angina or cardiac arrhythmias.…”
Section: Pharmacologymentioning
confidence: 99%
“…[11,13,14] Outside the cardiovascular system, voltage-gated L-type calcium channels are found in the beta cells of the pancreas, central nervous system and skeletal muscle. [11,13,14] Non-dihydropyridine CCBs are used primarily to treat angina or cardiac arrhythmias. [11,13] They are lipophilic and have a higher affinity for cardiomyocytes than the dihydropyridine agents, where they reduce the influx of calcium during phase two of the action potential.…”
Calcium channel blockers (CCBs) are commonly used in South Africa (SA) in the management of hypertension and other cardiovascular disease. Their ubiquitous availability makes them a common agent in drug overdose (OD), whether through accidental ingestion or deliberate self-harm. It is essential that medical practitioners know how to recognise and manage CCB OD, as severe CCB OD is often fatal. As there is a lack of local literature in SA, we highlight the general principles of management of CCB OD, as well as complications and problems that may be encountered during treatment. This narrative review is based on existing clinical guidelines, retrospective studies and systematic reviews on the emergency management of CCB OD. High-dose insulin euglycaemic therapy has become the mainstay of treatment in severe CCB OD. The rationale, the recommended protocol for its use and its adverse effects are described.S Afr Med J 2019;109(9):635-638. https://doi.
“…Table 1 presents a brief overview of these cases. 10,12,21,[23][24][25][26][27][28][29][30] Interestingly, HIET may be used for management of toxicity resulting from therapeutically dosed BBs. 31 One patient with a history of atrial fibrillation was receiving metoprolol 250 mg/ day.…”
Both calcium channel blockers (CCBs) and β blockers (BBs) are associated with fatal substance exposures within the United States. Cases of overdose with these agents have the potential to be both complex and difficult to manage. A variety of pharmacologic treatment options are available for clinicians to use to help mitigate harm from these poisonings. Hyperinsulinemic-euglycemic therapy (HIET) was once regarded as a last-ditch effort to treat patients in highly refractory cases. In recent years, this therapy has become a routine therapy in the treatment of CCB/BB overdose. This article provides a literature review regarding HIET in cases of overdose with CCB and BB agents. Relevant literature articles from 1997-2018 were identified and reviewed using the PubMed and Embase databases. The following search terms were used to identify potential articles: "hyperinsulinemic-euglycemic therapy," "overdose," "calcium channel blocker," "beta blocker," and "insulin." Articles published in the English language were included in this review. A manual search of reference lists was also conducted. Much of the literature is limited to case reports, series, retrospective chart reviews, and small prospective studies. The success rate observed in published case series ranged from 80.4-100%. Regular insulin is most commonly dosed at an initial bolus of 1 unit/kg followed by a regular insulin infusion of 0.5-1 unit/kg/hour. Euglycemia is often maintained using intravenous fluids containing dextrose. Hyperinsulinemic-euglycemic therapy exhibited a promising safety profile, provided close monitoring is conducted. More research is needed to determine optimal strategies for maintaining euglycemia, ideal monitoring parameters, and consistent efficacy goals.
“…Finally, noncardiogenic pulmonary edema is more commonly observed in CCB poisoning. [10][11][12] Phenylalkylamines Verapamil, fendiline, and gallapamil…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.